AKT1 and chronic myelogenous leukemia, BCR-ABL1 positive: Pathway enrichment analysis according to KEGG was mainly enriched in PI3K-Akt and AMPK signaling pathway, endometrial cancer, acute myeloid leukemia, colorectal cancer, central carbon metabolism in cancer, transcriptional misregulation in cancer, and chronic myeloid leukemia.